Supplements and Featured Publications

Exploring Further Avenues for Menin Inhibition in Acute Myeloid Leukemia

Volume: 1

Issue: 1

View Issue

Navigating Pediatric-Inspired Regimens in Acute Lymphoblastic Leukemia

Volume: 1

Issue: 1

View Issue

Gaining Insight Into Treatment Personalization in GIST

Volume: 1

Issue: 1

View Issue

Reviewing Recent Developments in ROS1-Positive NSCLC

Volume: 1

Issue: 1

View Issue

Data Informing Treatment Decisions and Strategies in HER2+ Breast Cancer

Volume: 1

Issue: 1

Supported in part by Daiichi Sankyo. Content produced and independently developed by OncLive.

View Issue

$Targeting PRAME in PD-1–Refractory Melanoma$

Targeting PRAME in PD-1–Refractory Melanoma

Volume: 1

Issue: 1

View Issue

Solidifying the Synergistic Activity of Toripalimab Plus Chemotherapy in Nasopharyngeal Carcinoma

Volume: 1

Issue: 1

View Issue

Unpacking Pivotal Data Updates in Metastatic Breast Cancer Management

Volume: 1

Issue: 1

Sponsored in part by AstraZeneca and Daiichi Sankyo. Content produced and independently developed by OncLive.

View Issue

Spotlight on the STAR-221 Trial in Gastric/GEJ/Esophageal Adenocarcinoma

Volume: 1

Issue: 1

View Issue

Navigating Novel Endocrine Therapies in ER+ Breast Cancer

Volume: 1

Issue: 1

View Issue

Going Beyond Immunotherapy in HPV-Negative Head and Neck Squamous Cell Carcinoma

Volume: 1

Issue: 1

View Issue

Addressing Treatment Adherence With Liquid Drug Formulations in CML and ALL

Volume: 1

Issue: 1

View Issue

Dissecting Emerging Data in Metastatic Breast Cancer

Volume: 1

Issue: 1

View Issue

The Evolving Role of ESR1 Mutations in Metastatic Breast Cancer

Volume: 1

Issue: 1

This supplement is funded by AstraZeneca. The publisher is solely responsible for this content. AstraZeneca does not recommend or endorse the use of its products other than as described in the approved labeling. The content of this supplement is not medical advice and does not replace independent medical judgment.

View Issue|Download Issue